$11.78
3.13% yesterday
Nasdaq, Jun 13, 10:00 pm CET
ISIN
US5907171046
Symbol
MESO
Sector
Industry

Mesoblast Limited Sponsored ADR Target price 2025 - Analyst rating & recommendation

Mesoblast Limited Sponsored ADR Classifications & Recommendation:

Buy
100%

Mesoblast Limited Sponsored ADR Price Target

Target Price $25.30
Price $11.78
Potential
Number of Estimates 3
3 Analysts have issued a price target Mesoblast Limited Sponsored ADR 2026 . The average Mesoblast Limited Sponsored ADR target price is $25.30. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 4 analysts: 4 Analysts recommend Mesoblast Limited Sponsored ADR to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Mesoblast Limited Sponsored ADR stock has an average upside potential 2026 of . Most analysts recommend the Mesoblast Limited Sponsored ADR stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Jun '24 2025
Estimates
Revenue Million $ 5.90 19.40
21.33% 228.81%
EBITDA Margin -1,108.98% -153.09%
35.77% 86.20%
Net Margin -1,490.85% -3,920.67%
36.54% 162.98%

4 Analysts have issued a sales forecast Mesoblast Limited Sponsored ADR 2025 . The average Mesoblast Limited Sponsored ADR sales estimate is

$19.4m
Unlock
. This is
242.15% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$25.8m 355.03%
Unlock
, the lowest is
$13.8m 143.39%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $5.9m 21.33%
2025
$19.4m 228.81%
Unlock
2026
$85.8m 342.46%
Unlock
2027
$304m 254.27%
Unlock
2028
$855m 181.21%
Unlock
2029
$471m 44.92%
Unlock

1 Analyst has issued a net profit forecast Mesoblast Limited Sponsored ADR 2025 . The average Mesoblast Limited Sponsored ADR net profit estimate is

$-761m
Unlock
. This is
635.96% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-761m 635.96%
Unlock
, the lowest is
$-761m 635.96%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-88.0m 7.41%
2025
$-761m 764.72%
Unlock
2026
$-691m 9.09%
Unlock
2027
$1.2b 275.00%
Unlock

Net Margin

2024 -1,490.85% 36.54%
2025
-3,920.67% 162.98%
Unlock
2026
-805.55% 79.45%
Unlock
2027
397.92% 149.40%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Jun '24 2025
Estimates
Earnings Per Share $ -0.09 -0.66
18.18% 633.33%
P/E negative
EV/Sales 81.94

1 Analysts have issued a Mesoblast Limited Sponsored ADR forecast for earnings per share. The average Mesoblast Limited Sponsored ADR EPS is

$-0.66
Unlock
. This is
633.33% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-0.66 633.33%
Unlock
, the lowest is
$-0.66 633.33%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-0.09 18.18%
2025
$-0.66 633.33%
Unlock
2026
$-0.60 9.09%
Unlock
2027
$1.05 275.00%
Unlock

P/E ratio

Current -135.11 70.31%
2025
-18.42 86.37%
Unlock
2026
-20.27 10.04%
Unlock
2027
11.58 157.13%
Unlock

Based on analysts' sales estimates for 2025, the Mesoblast Limited Sponsored ADR stock is valued at an EV/Sales of

81.94
Unlock
and an P/S ratio of
77.38
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 280.37 151.97%
2025
81.94 70.77%
Unlock
2026
18.52 77.40%
Unlock
2027
5.23 71.77%
Unlock
2028
1.86 64.44%
Unlock
2029
3.38 81.55%
Unlock

P/S ratio

Current 264.77 151.54%
2025
77.38 70.77%
Unlock
2026
17.49 77.40%
Unlock
2027
4.94 71.77%
Unlock
2028
1.76 64.44%
Unlock
2029
3.19 81.56%
Unlock

Current Mesoblast Limited Sponsored ADR Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
PIPER SANDLER COMPANIES
Locked
Locked
Locked Apr 06 2025
JEFFERIES
Locked
Locked
Locked Mar 05 2025
MAXIM GROUP
Locked
Locked
Locked Feb 27 2025
BELL POTTER SECURITIES
Locked
Locked
Locked Feb 26 2025
PIPER SANDLER COMPANIES
Locked
Locked
Locked Dec 19 2024
MAXIM GROUP
Locked
Locked
Locked Dec 18 2024
BELL POTTER SECURITIES
Locked
Locked
Locked Aug 28 2024
Analyst Rating Date
Locked
PIPER SANDLER COMPANIES:
Locked
Locked
Apr 06 2025
Locked
JEFFERIES:
Locked
Locked
Mar 05 2025
Locked
MAXIM GROUP:
Locked
Locked
Feb 27 2025
Locked
BELL POTTER SECURITIES:
Locked
Locked
Feb 26 2025
Locked
PIPER SANDLER COMPANIES:
Locked
Locked
Dec 19 2024
Locked
MAXIM GROUP:
Locked
Locked
Dec 18 2024
Locked
BELL POTTER SECURITIES:
Locked
Locked
Aug 28 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today